Use of calcined Mg-Al-hydrotalcite to enhance the stability of celecoxib in the amorphous form

被引:10
作者
Ambrogi, Valeria
Perioli, Luana
Marmottini, Fabio
Rossi, Carlo
机构
[1] Univ Perugia, Dipartimento Chim & Tecnol Farm, I-06123 Perugia, Italy
[2] Univ Perugia, Dipartimento Ingn Civile & Ambientale, I-06123 Perugia, Italy
关键词
celecoxib; amorphous form; solubility; physical stability;
D O I
10.1016/j.ejpb.2006.10.006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The use of compound in amorphous forms is a promising approach to improve solubility of poorly water-soluble drugs. However, during storage, amorphous state can spontaneously transform to the lower energy crystalline form and this is a limiting factor for a large commercial use of drugs. In this paper, calcined hydrotalcite was employed to support amorphous celecoxib and several preparations at different weight drug/carrier ratio were prepared. Solubility of celecoxib from the prepared systems was evaluated and its physical stability during storage at different conditions was examined as well. The results show that HTIc-calc can be used as a support of amorphous celecoxib with consequent improvement of drug solubility and physical stability. (C) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:253 / 259
页数:7
相关论文
共 24 条
[11]  
DOI N, 1985, JPN KOKAI TOKKYO KOH, V255, P719
[12]  
Gupta P, 2005, AAPS PHARMSCITECH, V6
[13]   Characteristics and significance of the amorphous state in pharmaceutical systems [J].
Hancock, BC ;
Zograf, G .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (01) :1-12
[14]   Improvement of solubility and oral bioavailability of a poorly water-soluble drug, TAS-301, by its melt-adsorption on a porous calcium silicate [J].
Kinoshita, M ;
Baba, K ;
Nagayasu, A ;
Yamabe, K ;
Shimooka, T ;
Takeichi, Y ;
Azuma, M ;
Houchi, H ;
Minakuchi, K .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 91 (02) :362-370
[15]  
KYOWA HAKKO KOGYO CO, 1985, Patent No. 6010039
[16]   Improving drug solubility for oral delivery using solid dispersions [J].
Leuner, C ;
Dressman, J .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2000, 50 (01) :47-60
[17]   INCREASING DISSOLUTION RATES OF POORLY SOLUBLE DRUGS BY ADSORPTION TO MONTMORILLONITE [J].
MCGINITY, JW ;
HARRIS, MR .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1980, 6 (01) :35-48
[18]   Preparation and characterization of glassy celecoxib [J].
Paradkar, AR ;
Chauhan, B ;
Yamamura, S ;
Pawar, AP .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2003, 29 (07) :739-744
[19]   Dissolution rate enhancement by adsorption of poorly soluble drugs on hydrophilic silica aerogels [J].
Smirnova, I ;
Suttiruengwong, S ;
Seiler, M ;
Arlt, W .
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2004, 9 (04) :443-452
[20]  
TRIFIRO F, 1996, SOLID STATE SUPRAMOL, V7, P1